Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 5071 AL 5085

Applications of Raman spectroscopy in the diagnosis and monitoring of neurodegenerative diseases

Chen C, Qi J, Li Y, Li D, Wu L, Li R, Chen Q, Sun N.

Front Neurosci. 2024 Feb 2;18:1301107. doi: 10.3389/fnins.2024.1301107. eCollection 2024.

Brain incoming call from glia during neuroinflammation: Roles of extracellular vesicles

D'Egidio F, Castelli V, d'Angelo M, Ammannito F, Quintiliani M, Cimini A.

Neurobiol Dis. 2024 Oct 15;201:106663. doi: 10.1016/j.nbd.2024.106663. Epub 2024 Sep 7.

Systematic Review and Meta-Analyses of Word Production Abilities in Dysfunction of the Basal Ganglia: Stroke, Small Vessel Disease, Parkinson's Disease, and Huntington's Disease

Camerino I, Ferreira J, Vonk JM, Kessels RPC, de Leeuw FE, Roelofs A, Copland D, Piai V.

Neuropsychol Rev. 2024 Mar;34(1):1-26. doi: 10.1007/s11065-022-09570-3. Epub 2022 Dec 24.

Huntington's Disease: A Report of an Interesting Case and Literature Review

Sharma PK, Aram A, Polaka Y, Pandian V.

Cureus. 2024 Mar 3;16(3):e55443. doi: 10.7759/cureus.55443. eCollection 2024 Mar.

Therapeutic approaches targeting aging and cellular senescence in Huntington's disease

Bhat AA, Moglad E, Afzal M, Thapa R, Almalki WH, Kazmi I, Alzarea SI, Ali H, Pant K, Singh TG, Dureja H, Singh SK, Dua K, Gupta G, Subramaniyan V.

CNS Neurosci Ther. 2024 Oct;30(10):e70053. doi: 10.1111/cns.70053.

The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans

Fabi JP.

Metab Brain Dis. 2024 Jun;39(5):967-984. doi: 10.1007/s11011-024-01369-w. Epub 2024 Jun 7.

COVID-19 Vaccine-Related Movement Disorders: A Systematic Review

Angeles GED, Dichoso LPC, Jamora RDG.

J Mov Disord. 2024 Jul;17(3):322-327. doi: 10.14802/jmd.24001. Epub 2024 Mar 19.

Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer's, Parkinson's, and ALS

Toader C, Tataru CP, Munteanu O, Serban M, Covache-Busuioc RA, Ciurea AV, Enyedi M.

Int J Mol Sci. 2024 Nov 24;25(23):12613. doi: 10.3390/ijms252312613.

Pathomechanisms of behavioral abnormalities in Huntington disease: an update

Jellinger KA.

J Neural Transm (Vienna). 2024 Sep;131(9):999-1012. doi: 10.1007/s00702-024-02794-y. Epub 2024 Jun 14.

Deciphering Cognitive Impairments in Huntington's Disease: A Comparative Study of Stroop Test Variations

Sierra LA, Wynn A, Lanzaro E, Dzekon K, Russell A, Halko M, Claassen DO, Frank S, Considine CM, Laganiere S.

J Huntingtons Dis. 2024;13(2):249-257. doi: 10.3233/JHD-231528.

Overcoming Graft Rejection in Induced Pluripotent Stem Cell-Derived Inhibitory Interneurons for Drug-Resistant Epilepsy

Beaudreault CP, Wang R, Muh CR, Rosenberg A, Funari A, McGoldrick PE, Wolf SM, Sacknovitz A, Chung S.

Brain Sci. 2024 Oct 16;14(10):1027. doi: 10.3390/brainsci14101027.

The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease

Pérot JB, Brouillet E, Flament J.

Front Aging Neurosci. 2024 Feb 13;16:1306312. doi: 10.3389/fnagi.2024.1306312. eCollection 2024.

Large animal models for Huntington's disease research

Han B, Liang W, Li XJ, Li S, Yan S, Tu Z.

Zool Res. 2024 Mar 18;45(2):275-283. doi: 10.24272/j.issn.2095-8137.2023.199.

Exploring the Comprehensive Neuroprotective and Anticancer Potential of Afzelin

Kciuk M, Garg N, Dhankhar S, Saini M, Mujwar S, Devi S, Chauhan S, Singh TG, Singh R, Marciniak B, Gielecińska A, Kontek R.

Pharmaceuticals (Basel). 2024 May 28;17(6):701. doi: 10.3390/ph17060701.

Mitochondrial targeted antioxidants as potential therapy for huntington's disease

Upadhayay S, Kumar P.

Pharmacol Rep. 2024 Aug;76(4):693-713. doi: 10.1007/s43440-024-00619-z. Epub 2024 Jul 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias